by EmpathiCSubstanceS | May 2, 2018 | Addiction, Anxiety
hree years later Daniel Kreitman still chokes up when he talks about what he saw, and how it changed him. Kreitman, an upholsterer by trade, had taken psilocybin, a hallucinogen derived from mushrooms, in a trial at Johns Hopkins University School of Medicine for...
by EmpathiCSubstanceS | May 2, 2018 | Addiction, Anxiety
Patients unresponsive to conventional treatments benefit when treated with natural psychoactive compound, but researchers warn against self medication. Magic mushrooms may effectively “reset” the activity of key brain circuits known to play a role in depression, the...
by EmpathiCSubstanceS | May 1, 2018 | Anxiety, Bipolar Disorder
By R. Andrew Sewell With the current renaissance in psychedelic research, after a forty-year moratorium, undergraduates interested in the topic are increasingly starting to ask: How can I get involved? Unfortunately, psychedelics are still heavily stigmatized, and...
by EmpathiCSubstanceS | Mar 29, 2018 | Addiction, Anxiety
DMT is a psychedelic drug that is found in many plants and animals, including humans. Recreationally DMT is usually smoked or injected. In the 90s, a researcher asked people to take the drug and report back what they experienced. Volunteers said they experienced...
by EmpathiCSubstanceS | Mar 21, 2018 | Addiction, Anxiety
The hippie adage, “Turn on, tune in, drop out,” now comes with a modern addendum: “Get federal funding.” January marked the 50th anniversary of the Human Be-In, the historic drug policy protest that attracted tens of thousands of people to San...
by EmpathiCSubstanceS | Mar 21, 2018 | Anxiety, Bipolar Disorder
By Richard Haridy A fascinating study led by scientists at the University of Zurich has uncovered key insights into the mechanisms behind how our brain generates our sense of self. The researchers administered lysergic acid diethylamide (LSD) to several participants...
